Eagle Pharmaceuticals Inc (EGRX)
4.47
-0.30
(-6.29%)
USD |
NASDAQ |
Apr 24, 14:35
Eagle Pharmaceuticals Revenue (Quarterly): 64.65M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 64.65M |
| March 31, 2023 | 66.30M |
| December 31, 2022 | 60.70M |
| September 30, 2022 | 65.90M |
| June 30, 2022 | 74.14M |
| March 31, 2022 | 115.87M |
| December 31, 2021 | 42.32M |
| September 30, 2021 | 39.85M |
| June 30, 2021 | 48.12M |
| March 31, 2021 | 41.25M |
| December 31, 2020 | 49.92M |
| September 30, 2020 | 49.93M |
| June 30, 2020 | 41.94M |
| March 31, 2020 | 46.02M |
| December 31, 2019 | 48.26M |
| September 30, 2019 | 41.15M |
| June 30, 2019 | 56.70M |
| March 31, 2019 | 49.78M |
| December 31, 2018 | 56.05M |
| September 30, 2018 | 51.34M |
| June 30, 2018 | 59.30M |
| March 31, 2018 | 46.63M |
| Date | Value |
|---|---|
| December 31, 2017 | 46.78M |
| September 30, 2017 | 63.02M |
| June 30, 2017 | 50.11M |
| March 31, 2017 | 76.79M |
| December 31, 2016 | 81.14M |
| September 30, 2016 | 37.83M |
| June 30, 2016 | 40.92M |
| March 31, 2016 | 29.59M |
| December 31, 2015 | 18.18M |
| September 30, 2015 | 5.736M |
| June 30, 2015 | 6.002M |
| March 31, 2015 | 36.31M |
| December 31, 2014 | 5.60M |
| September 30, 2014 | 2.811M |
| June 30, 2014 | 5.792M |
| March 31, 2014 | 5.005M |
| December 31, 2013 | 5.492M |
| September 30, 2013 | 4.640M |
| June 30, 2013 | 5.075M |
| March 31, 2013 | 2.481M |
| December 31, 2012 | 1.483M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
39.85M
Minimum
Sep 2021
115.87M
Maximum
Mar 2022
56.06M
Average
49.92M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 192.51M |
| Soligenix Inc | -- |
| Marinus Pharmaceuticals Inc | 7.19M |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.164M |
| Total Expenses (Quarterly) | 54.34M |
| EPS Diluted (Quarterly) | 0.39 |